In vivo experiments, Cul4A-RNAi combined with gemcitabine chemotherapy inhibited lung cancer tumor growth, suggesting that this combination may provide a new approach for lung cancer treatment (Hung et al., 2015). This evidence concerns the gene CUL4A and lung cancer.